Quantitative method for Hex4, lyso-GM1, Fuc-GlcNAc-Asn, and lyso-sulfatide in cerebrospinal fluid
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2024-12-04
- Publication Date
- 2026-06-16
Smart Images

Figure 0007874706000085 
Figure 0007874706000086 
Figure 0007874706000087
Abstract
Claims
1. A method for quantifying lyso-sulfatide contained in cerebrospinal fluid, The steps include adding an internal standard substance to a solution containing cerebrospinal fluid, The steps include: obtaining an eluate by subjecting a solution containing cerebrospinal fluid to which the internal standard substance has been added to liquid chromatography; The step of subjecting the eluate to mass spectrometry, It consists of, A method wherein the internal standard is represented by the following formula [X]. 【Chemistry 10】
2. The method according to claim 1, wherein the liquid chromatography is reversed-phase chromatography.
3. The method according to claim 1 or 2, wherein the lyso-sulfatide is measured in comparison with an internal standard.
4. The method according to any one of claims 1 to 3, wherein the cerebrospinal fluid is obtained from a patient with a disease in which lyso-sulfatide and / or sulfatide accumulates in the body.
5. The method according to claim 4, wherein the disease is metachromatic leukodystrophy.
6. The method according to claim 4 or 5, wherein the patient has received treatment to reduce the amount of lyso-sulfatide and / or sulfatide present in the body.
Citation Information
Patent Citations
Diagnostic methods for Pompe disease and other glycogen storage diseases
JP2004501365A
How to diagnose metachromatic leukodystrophy
JP2016506501A
Method for analyzing glycosaminoglycan
JP2019060837A
Lipid profile as a biomarker for early detection of neurological disorders
US20090029473A1
Method for assaying glycosphingolipid
WO2012081508A1